We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App




LGC Clinical Diagnostics and AccuGenomics Collaborate on Enhancing Cancer Testing Accuracy

By LabMedica International staff writers
Posted on 11 Oct 2024

LGC (London, UK), a global leader in clinical diagnostics and genomics, and AccuGenomics (Wilmington, NC, USA), a pioneer in molecular diagnostic development, have entered into a new strategic partnership to combine LGC’s expertise in quality control solutions with AccuGenomics’ advanced NGS monitoring technologies, driving innovation in clinical diagnostic tools. More...

The companies will focus on developing highly accurate and reliable molecular diagnostics and quality control materials, fulfilling the vital needs of precision medicine and improving patient management. Through this collaboration, LGC and AccuGenomics intend to deliver enhanced solutions for cancer NGS testing quality control. LGC’s extensive clinical genomics reference material expertise, combined with AccuGenomics’ proprietary technology, will allow laboratories across the world to integrate third party controls into their procedures, ensuring more reliable, actionable patient results from NGS-based assays. Additionally, the companies will also develop custom reference materials for NGS assay validation, supporting the evolving landscape of precision diagnostics. LGC and AccuGenomics expect this collaboration to speed up the adoption of NGS technologies in clinical laboratories across the world.

“We are delighted to partner with AccuGenomics to further our mission of providing laboratories with cutting-edge quality control solutions,” said Bharathi Anekella, Executive Vice President of LGC. “This collaboration aligns perfectly with our vision of advancing global diagnostics and supporting healthcare providers with the tools they need to deliver better patient outcomes.”

“This partnership with LGC will expand the reach of our proprietary technologies and enable more laboratories to improve the reliability of their patient testing by NGS,” added Nick Lazaridis, President of AccuGenomics. “LGC is well aligned across the diagnostic, therapeutic and pharmaceutical sectors as a strategic distribution partner. Our focus is on improving the accuracy and sensitivity of challenging NGS applications like liquid biopsy detection for MRD; this partnership with LGC will accelerate the adoption of Accukit ctDNA MRD IS, and Accukit Myeloid DNA IS. Together, we can contribute to the development of more precise life-saving diagnostic tools that support personalized medicine, leading to more accurate clinical NGS tests.”

Related Links:
LGC 
AccuGenomics


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hemodynamic System Monitor
OptoMonitor
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The VeraBIND Tau assay is a novel blood test that identifies the presence of active tau pathology (Photo courtesy of 123RF)

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals

Alzheimer’s disease (AD), the sixth leading cause of death in the United States, affects an estimated 7.2 million Americans aged 65 or older. Current diagnostic methods for AD are often invasive, expensive,... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.